Opportunities for the use of lentiviral vectors in human gene therapy.
Galimi
F
F
Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA.
Verma
I M
IM
D000818:Animals; D002493:Central Nervous System Diseases / Q000628:therapy; D015316:Genetic Therapy / Q000009:adverse effects; D005822:Genetic Vectors / Q000009:adverse effects; D015658:HIV Infections / Q000628:therapy; D006412:Hematopoietic Stem Cells; D006801:Humans; D016086:Lentivirus / Q000235:genetics*; D007966:Leukodystrophy, Metachromatic / Q000628:therapy; D008099:Liver; D016538:Mucopolysaccharidosis VII / Q000628:therapy; D018482:Muscle, Skeletal; D010300:Parkinson Disease / Q000628:therapy; D012162:Retinal Degeneration / Q000628:therapy; D012449:Safety